NCT00735020View on ClinicalTrials.gov

Study to Evaluate Safety, Tolerability and Immunogenicity of a Bedside Mixing Combination of Two Adjuvanted Influenza Vaccines

PHASE1CompletedINTERVENTIONAL

Enrollment

72

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions

Influenza

Interventions

BIOLOGICAL

Adjuvanted Influenza Vaccine

1 dose of Adjuvanted Influenza Vaccine

BIOLOGICAL

Influenza Vaccine

1 dose of Influenza Vaccine

Trial Locations (1)

36 6853

I.P.A.S., Ligornetto

Sponsors

Lead Sponsor

Novartis Vaccines

All Listed Sponsors

lead

Novartis Vaccines

INDUSTRY